genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2017
DNA vaccine
Drug Discovery
Immunomic Licenses CMV-Targeting Tech from Annias for LAMP-Vax Cancer Vaccines
Drug Discovery
Astellas Licenses Exclusive Rights to Immunomic’s LAMP-vax DNA Vaccine Platform
Insights
Not Your “Old School” Immune System
News
$1.2M in Grants Awarded for Alzheimer’s Studies in People with Down Syndrome
Insights
DNA Vaccines Free from Mobile DNA
Drug Discovery
Roche Signs Up to $422.5M Collaboration with Inovio
Drug Discovery
Inovio Wins $3.5M NIAID Grant to Advance Vaccine Device
Insights
Tackling Transfection Tasks
Bioprocessing
Aldevron to Produce CureLab’s DNA Vaccine for Cancer
Drug Discovery
Viral Load Assay Employed for Phase III CMV Vaccine Trial
1
2
3
4
...
7
Page 3 of 7
Scroll Up
Scroll Up
